Complement C3a receptor inactivation attenuates retinal degeneration induced by oxidative damage

Area of Science:

• Ophthalmology
• Neuroscience
• Immunology

Background:

• Retinal degeneration is a leading cause of vision loss in the elderly.
• Complement system activation is implicated in retinal degeneration, but mechanisms are unclear.
• Understanding complement signaling is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the role of the complement system, specifically C3 and C3a receptor (C3ar1), in retinal degeneration.
• To elucidate the molecular mechanisms linking C3ar1 to neuroinflammation and photoreceptor cell death.
• To evaluate the therapeutic potential of targeting the C3ar1 pathway.

Main Methods:

• Assessed C3 and C3ar1 expression in retinal degeneration models.
• Utilized genetic deletion of C3 and pharmacological inhibition of C3ar1.
• Performed RNA sequencing (RNA-seq) to identify C3ar1-regulated networks.
• Investigated the involvement of STAT3 downstream of the C3ar1 pathway.

Main Results:

• C3 and C3ar1 expression correlated positively with inflammation and retinal degeneration.
• C3 deletion and C3ar1 inhibition alleviated neuroinflammation and protected photoreceptor cells.
• RNA-seq revealed a C3ar1-dependent network regulating microglial activation and astrocyte gliosis.
• The C3ar1-STAT3 pathway was identified as a key mediator of immune response and degeneration under oxidative stress.

Conclusions:

• C3a receptor (C3ar1) plays a critical role in oxidative stress-induced retinal degeneration.
• Targeting the C3ar1 pathway demonstrates therapeutic potential for alleviating retinal degeneration.
• The C3ar1-STAT3 pathway is a key mechanism driving immune responses and cell death in the retina.